C. Fang

Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer

P. Gibbs, O. Sieber, J. Mariadason, 2019, Modern Pathology.

Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation

P. Gibbs, O. Sieber, R. Ward, 2020, Modern Pathology.

Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

A. Scott, R. Simpson, G. O'Keefe, 2016, Oncotarget.

Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

A. Scott, R. Simpson, G. O'Keefe, 2015, Oncotarget.

Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes

R. Jorissen, P. Gibbs, O. Sieber, 2018, Gut.

Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma

N. Tebbutt, J. Sachinidis, C. Christophi, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.

David S. Williams, C. Fang, N. Jing, 2017, Pathology.